본문 바로가기
KERD
논문KCI 등재

Body fat composition and miR-378 expression profiling in patients with type 1 diabetes

0

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류소아과학

초록

Purpose: Type 1 diabetes (T1D) is an autoimmune disease that involves genetic, epigenetic, and environmental factors. Change in body composition is a potential mechanism for explaining the increased incidence of T1D. Micro RNA-378 (miRNA-378) is a positive regulator of adipogenesis that has yet to be studied in such patients. This study aims to evaluate the miRNA-378 expression profile in peripheral mononuclear cells of T1D patients and controls and to determine its possible association with levels of body fat, interleukin-6 (IL-6), and tumor necrosis factor alpha (TNF-α). Methods: Twenty-four T1D subjects and 20 controls under 18 years of age without autoimmune diseases were studied. miRNA-378 expression profile was determined by TaqMan probes. Body composition was determined by multifrequency bioimpedance. IL-6 and TNF-α serum levels were determined by LUMINEX. Anti-GAD65, anti-IA2, and anti-ZnT8 antibodies were quantified in serum by enzyme immunoassays. Statistical significance was considered P<0.05. Results: Similar body mass index and body fat (kg) were observed between the T1D and control subjects (P=0.55 and P=0.69, respectively). The miRNA-378 expression profile was significantly higher in T1D patients compared with the controls (P<0.05). Lower miRNA-378 expression in prepubertal controls was observed compared to pubertal controls, prepubertal T1D, and pubertal T1D (P<0.05). AntiGAD65, AntilA2, and AntiZnT8 were positively correlated with miRNA-378 (P=0.002, P=0.053, and P=0.007). No statistically significant correlation was observed between miRNA-378 expression and IL-6, TNF-α, or body fat. Conclusion: Elevated miRNA-378 expression in T1D patients compared with controls is linked to pubertal stage but is not associated with proinflammatory status or body composition.

Abstract

Purpose: Type 1 diabetes (T1D) is an autoimmune disease that involves genetic, epigenetic, and environmental factors. Change in body composition is a potential mechanism for explaining the increased incidence of T1D. Micro RNA-378 (miRNA-378) is a positive regulator of adipogenesis that has yet to be studied in such patients. This study aims to evaluate the miRNA-378 expression profile in peripheral mononuclear cells of T1D patients and controls and to determine its possible association with levels of body fat, interleukin-6 (IL-6), and tumor necrosis factor alpha (TNF-α). Methods: Twenty-four T1D subjects and 20 controls under 18 years of age without autoimmune diseases were studied. miRNA-378 expression profile was determined by TaqMan probes. Body composition was determined by multifrequency bioimpedance. IL-6 and TNF-α serum levels were determined by LUMINEX. Anti-GAD65, anti-IA2, and anti-ZnT8 antibodies were quantified in serum by enzyme immunoassays. Statistical significance was considered P<0.05. Results: Similar body mass index and body fat (kg) were observed between the T1D and control subjects (P=0.55 and P=0.69, respectively). The miRNA-378 expression profile was significantly higher in T1D patients compared with the controls (P<0.05). Lower miRNA-378 expression in prepubertal controls was observed compared to pubertal controls, prepubertal T1D, and pubertal T1D (P<0.05). AntiGAD65, AntilA2, and AntiZnT8 were positively correlated with miRNA-378 (P=0.002, P=0.053, and P=0.007). No statistically significant correlation was observed between miRNA-378 expression and IL-6, TNF-α, or body fat. Conclusion: Elevated miRNA-378 expression in T1D patients compared with controls is linked to pubertal stage but is not associated with proinflammatory status or body composition.

참고문헌 (40)

  1. Pugliese A, "The multiple origins of type 1 diabetes", Diabet Med, 30, pp.135~146 (2013)
  2. Nokoff N, "Pathogenesis of type 1 diabetes : lessons from natural history studies of high-risk individuals", Ann N Y Acad Sci, 1281, pp.1~15 (2013)
  3. Carrasco E, "One of the lowest validated incidence rates of insulin dependent diabetes mellitus in the Americas: Santiago, Chile", Diabetes Res Clin Pract, 34(Suppl), pp.S153~S157 (1996)
  4. Carrasco E, "Increasing incidence of type 1 diabetes in population from Santiago of Chile: trends in a period of 18 years (1986-2003)", Diabetes Metab Res Rev, 22, pp.34~37 (2006)
  5. Hewagama A, "The genetics and epigenetics of autoimmune diseases", J Autoimmun, 33, pp.3~11 (2009)
  6. Wang YC, "Health and economic burden of the projected obesity trends in the USA and the UK", Lancet, 378, pp.815~825 (2011)
  7. "Informe Mapa Nutricional 2015" (2016)[URL]
  8. Weisberg SP, "Obesity is associated with macrophage accumulation in adipose tissue", J Clin Invest, 112, pp.1796~1808 (2003)
  9. Hotamisligil GS, "Adipose expression of tumor necrosis factor-alpha : direct role in obesity-linked insulin resistance", Science, 259, pp.87~91 (1993)
  10. Poy MN, "A pancreatic islet-specific microRNA regulates insulin secretion", Nature, 432, pp.226~230 (2004)
  11. Ono K, "MicroRNA links obesity and impaired glucose metabolism", Cell Res, 21, pp.864~866 (2011)
  12. Xu LL, "TNF-α, IL-6, and leptin increase the expression of miR-378, an adipogenesis-related microRNA in human adipocytes", Cell Biochem Biophys, 70, pp.771~776 (2014)
  13. Carrer M, "Control of mitochondrial metabolism and systemic energy homeostasis by microRNAs 378 and 378*", Proc Natl Acad Sci U S A, 109, pp.15330~15335 (2012)
  14. Kahai S, "MicroRNA miR-378 regulates nephronectin expression modulating osteoblast differentiation by targeting GalNT-7", PLoS One, 4, pp.e7535~ (2009)
  15. Lee DY, "MicroRNA-378promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expression", Proc Natl Acad Sci U S A, 104, pp.20350~20355 (2007)
  16. WHO Multicentre Growth Reference Study Group, "WHO child growth standards: Length", height-for-age, weightfor-age, weight-for-length, weight-for-height and body mass index-for-age: methods and development, 2006
  17. Flechtner-Mors M, "Overweight and obesity based on four reference systems in 18, 382paediatric patients with type 1 diabetes from Germany and Austria", J Diabetes Res, 2015, pp.370753~ (2015)
  18. DuBose SN, "Obesity in youth with type 1 diabetes in Germany, Austria, and the United States", J Pediatr, 167, pp.627-32.e1~627-32.e4 (2015)
  19. Mosso C, "Dietary intake, body composition, and physical activity among young patients with type 1 diabetes mellitus", J Pediatr Endocrinol Metab, 28, pp.895~902 (2015)
  20. Gregory JW, "Body fat and overweight among children and adolescents with diabetes mellitus", Diabet Med, 9, pp.344~348 (1992)
  21. Ahmed ML, "Elevated leptin levels are associated with excess gains in fat mass in girls, but not boys, with type 1 diabetes : longitudinal study during adolescence", J Clin Endocrinol Metab, 86, pp.1188~1193 (2001)
  22. Manyanga T, "Not as skinny as we used to think : Body mass index in children and adolescents at diagnosis of type 1 diabetes mellitus", J Diabetes Complications, 30, pp.292~294 (2016)
  23. Holl RW, "Contributions of age, gender and insulin administration to weight gain in subjects with IDDM", Diabetologia, 41, pp.542~547 (1998)
  24. Dunger D, "Growth and body composition in type 1 diabetes mellitus", Horm Res, 58(Suppl 1), pp.66~71 (2002)
  25. Smart CE, "ISPAD Clinical Practice Consensus Guidelines 2014. Nutritional management in children and adolescents with diabetes", Pediatr Diabetes, 15(Suppl 20), pp.135~153 (2014)
  26. Abd El Dayem SM, "Bone density, body composition, and markers of bone remodeling in type 1 diabetic patients", Scand J Clin Lab Invest, 71, pp.387~393 (2011)
  27. Paulino MF, "Growth and body composition in children with type 1 diabetes mellitus", Arch Bras Endocrinol Metab, 50, pp.490~498 (2006)
  28. Lipsky LM, "Body mass index and adiposity indicators associated with cardiovascular biomarkers in youth with type 1 diabetes followed prospectively", Pediatr Obes, 12, pp.468~476 (2017)
  29. Alnek K, "Increased blood levels of growth factors, proinflammatory cytokines, and th17 cytokines in patients with newly diagnosed type 1 diabetes", PLoS One, 10, pp.e0142976~ (2015)
  30. Dufour CR, "Genome-wide orchestration of cardiac functions by the orphan nuclear receptors ERRalpha and gamma", Cell Metab, 5, pp.345~356 (2007)
  31. Lowell BB, "Mitochondrial dysfunction and type 2 diabetes", Science, 307, pp.384~387 (2005)
  32. Patti ME, "Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes:Potential role of PGC1 and NRF1", Proc Natl Acad Sci U S A, 100, pp.8466~8471 (2003)
  33. Ishida M, "MicroRNA-378 regulates adiponectin expression in adipose tissue: a new plausible mechanism", PLoS One, 9, pp.e111537~ (2014)
  34. Gerin I, "Roles for miRNA-378", 378* in adipocyte gene expression and lipogenesis, 2010, pp.299, E198~E206
  35. Assmann TS, "MicroRNA expression profiles and type 1diabetes mellitus : systematic review and bioinformatic analysis", Endocr Connect, 6, pp.773~790 (2017)
  36. Perrini S, "Fat depot-related differences in gene expression, adiponectin secretion, and insulin action and signalling in human adipocytes differentiated in vitro from precursor stromal cells", Diabetologia, 51, pp.155~164 (2008)
  37. Wilkin TJ, "The accelerator hypothesis : a review of the evidence for insulin resistance as the basis for type I as well as type II diabetes", Int J Obes(Lond), 33, pp.716~726 (2009)
  38. Park E, "Estrogen receptor-related receptor γ regulates testicular steroidogenesis through direct and indirect regulation of steroidogenic gene expression", Mol Cell Endocrinol, 452, pp.15~24 (2017)
  39. Salas-Pérez F, "MicroRNAs miR-21a and miR-93 are down regulated in peripheral blood mononuclear cells(PBMCs)from patients with type 1 diabetes", Immunobiology, 218, pp.733~737 (2013)
  40. Sebastiani G, "Increased expression of microRNA miR-326 in type 1 diabetic patients with ongoing islet autoimmunity", Diabetes Metab Res Rev, 27, pp.862~866 (2011)

관련 논문AI추천

Preserved C-peptide levels in overweight or obese compared with underweight children upon diagnosis of type 1 diabetes mellitus신충호, 양세원, 이영아, 이윤정, 조원임, Hyeoh Won Yu대한소아내분비학회 · Annals of Pediatric Endocrinology & Metabolism2015 · 제20권 제2호Impacts of circulating cytokine levels and gene polymorphism predisposition on type 1 diabetes mellitusAlghamdi Ahmed H., El-Refaei Mohamed F., El-Sherbini Sherif M., Mady Essam A., Shatla Ibrahim M.대한소아내분비학회 · Annals of Pediatric Endocrinology & Metabolism2024 · 제29권 제4호Comparison of proinsulin to C-peptide ratio in children with and without type 1 diabetes and its relation to ageBenjamin R. Ellison, Daniel S. Hsia, Jeffrey H. Burton대한소아내분비학회 · Annals of Pediatric Endocrinology & Metabolism2020 · 제25권 제1호Evaluation of bone mineral status in prepuberal children with newly diagnosed type 1 diabetes노정기, 박규정, 윤종서, 이해상, 임정섭, 황진순대한소아내분비학회 · Annals of Pediatric Endocrinology & Metabolism2018 · 제23권 제3호Predictors of associated and multiple autoimmunity in children and adolescents with type 1 diabetes mellitusKafassi Nikolitsa, Kakleas Konstantinos, Karanasios Spyridon, Karavanaki Kyriaki, Korona Anastasia, Kossyva Lydia대한소아내분비학회 · Annals of Pediatric Endocrinology & Metabolism2022 · 제27권 제3호Thyroid autoimmunity in children and adolescents with newly diagnosed type 1 diabetes mellitus김민선, 김찬종, 양은미, 이대열, 정의석, 한동균대한소아내분비학회 · Annals of Pediatric Endocrinology & Metabolism2014 · 제19권 제2호

이 간행물의 다른 논문 (9건)